Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 128

Results For "ANDA"

2095 News Found

NHA join hands with NABH to expedite implementation of ABDM
Policy | October 19, 2022

NHA join hands with NABH to expedite implementation of ABDM

NABH shall encourage and provide assistance in onboarding their accredited/certified facilities on ABDM’s Health Facility Registry


Zydus receives tentative approval from USFDA for Roflumilast tablets
Drug Approval | October 18, 2022

Zydus receives tentative approval from USFDA for Roflumilast tablets

Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data


Zydus receives tentative approval from USFDA for Valbenazine capsules
Drug Approval | October 18, 2022

Zydus receives tentative approval from USFDA for Valbenazine capsules

Valbenazine Capsules had annual sales of US $781 million in the United States according to IQVIA data


Elekta and HCG launch collaborative clinical educational facility in Mumbai
News | October 15, 2022

Elekta and HCG launch collaborative clinical educational facility in Mumbai

The training center will focus on providing radiation oncologists, radiotherapy technologists, and medical physicists with the necessary skills


Aster DM Healthcare signs Corporate TB Pledge
Healthcare | October 15, 2022

Aster DM Healthcare signs Corporate TB Pledge

Periodic community awareness program through Aster’s DM Healthcare’s visual media and social media platforms and implementing TB control activity through Aster Pharmacies across South India


JB Pharma publishes its maiden sustainability report
Sustainability | October 14, 2022

JB Pharma publishes its maiden sustainability report

Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%


Roche Diagnostics and Apollo Hospitals puts spotlight on safe blood for transfusion
News | October 14, 2022

Roche Diagnostics and Apollo Hospitals puts spotlight on safe blood for transfusion

The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year


Celanese support the sustained-release drug delivery market
News | October 13, 2022

Celanese support the sustained-release drug delivery market

Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions


Piramal Pharma Solutions launches ADCelerate
News | October 13, 2022

Piramal Pharma Solutions launches ADCelerate

ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission